TC BioPharm (Holdings) plc Warrants
TCBPW
TCBPW was delisted on the 21st of March, 2025.
6 hedge funds and large institutions have $14.2K invested in TC BioPharm (Holdings) plc Warrants in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
1% more capital invested
Capital invested by funds: $14.1K → $14.2K (+$88)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$11.6K |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$87 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21 |
| 4 |
AC
Armistice Capital
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$343 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Wolverine Asset Management
Chicago,
Illinois
| $6.62K | +$11.6K | +668,324 | New |
|
|
KC
2
Kepos Capital
New York
| $5K | – | – | – |
|
|
NCM
3
Nantahala Capital Management
New Canaan,
Connecticut
| $2.33K | – | – | – |
|
|
CAG
4
Csenge Advisory Group
Clearwater,
Florida
| $236 | +$87 | +5,000 | +27% |
|
|
5
UBS Group
Zurich,
Switzerland
| $24 | +$21 | +1,219 | +103% |
|
|
AC
6
Armistice Capital
New York
| $2 | +$3 | +188 | New |
|
|
ACM
7
Altium Capital Management
New York
| – | -$343 | -18,823 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$1 | -71 | Closed |
|
TCBPW Hedge Fund Activity: Q4 2024 in Review
6 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q4 2024, worth a combined $14.2K — up 0.62% from $14.1K a quarter earlier.
Fund positioning in TCBPW was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $11.6K. The largest seller was Altium Capital Management, exiting entirely with an estimated $343 sold.
- 6 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $14.2K of TC BioPharm (Holdings) plc Warrants stock for Q4 2024, up 0.62% quarter-over-quarter.
- 2 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q4 2024 and 2 closed out, a net change of 0 holders.
- The largest TC BioPharm (Holdings) plc Warrants buyer in Q4 2024 was Wolverine Asset Management, an estimated $11.6K added.
- The largest TC BioPharm (Holdings) plc Warrants seller in Q4 2024 was Altium Capital Management, an estimated $343 sold.
Based on aggregated 13F filings for Q4 2024.